# Hikma Pharmaceuticals USA Inc., Cherry Hill, NJ – FDA Inspections

Source: https://www.keypedia.com/companies/hikma-pharmaceuticals-usa-inc/646ab738-7dde-4473-abdb-76058836c610

> Inspection records and compliance data for Hikma Pharmaceuticals USA Inc. in Cherry Hill, New Jersey. 19 FDA inspections on record, 2 Form 483s, last inspected May 13, 2026.

---

## Details

- Name: Hikma Pharmaceuticals USA Inc.
- FEI Number: 2220525
- Facility Type: Outsourcing Facility
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK, REPACK
- Address Line 1: 2 Esterbrook Ln
- City: Cherry Hill
- State: New Jersey
- Zip Code: 08003
- Country Name: United States
- Address: 2 Esterbrook Ln, Cherry Hill, New Jersey 08003, United States
- Country: United States

## Related Documents

- [CRL - Hikma Pharmaceuticals USA Inc. - Unknown Date](https://www.keypedia.com/records/crl/hikma-pharmaceuticals-usa-inc/830344a3-afdc-4f95-b595-813aa987af98) — source: FDA, date: Invalid Date
- [CRL - Hikma Pharmaceuticals USA Inc. - Unknown Date](https://www.keypedia.com/records/crl/hikma-pharmaceuticals-usa-inc/ab63be0b-a852-448b-afee-fa7410134f6c) — source: FDA, date: Invalid Date
- [CRL - Hikma Pharmaceuticals USA Inc. - Unknown Date](https://www.keypedia.com/records/crl/hikma-pharmaceuticals-usa-inc/310294a7-b78f-4218-bb64-f8d5e6ee320c) — source: FDA, date: Invalid Date
- FDA Inspection 1304368 - Hikma Pharmaceuticals USA Inc. - 2026-05-13 — source: FDA, date: May 13, 2026
- [483 - Hikma Pharmaceuticals USA Inc. - 2024-06-12](https://www.keypedia.com/records/483/hikma-pharmaceuticals-usa-inc/971b3ca6-91d8-4cb0-8e87-87f250b0d2ab) — source: FDA, date: June 12, 2024
- [FDA Inspection 1237333 - Hikma Pharmaceuticals USA Inc. - 2024-06-12](https://www.keypedia.com/records/fda_inspections/hikma-pharmaceuticals-usa-inc/c508334e-3cc5-450a-a665-5fb2a067f1ed) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 12, 2024
- [483 - Hikma Pharmaceuticals USA Inc. - 2023-11-03](https://www.keypedia.com/records/483/hikma-pharmaceuticals-usa-inc/0d798230-9ea1-4d9b-8d2e-ffbff634ff89) — source: FDA, date: November 3, 2023
- [FDA Inspection 1222115 - Hikma Pharmaceuticals USA Inc. - 2023-11-03](https://www.keypedia.com/records/fda_inspections/hikma-pharmaceuticals-usa-inc/e7b030d5-aa1b-472b-8874-97ba0cb35d84) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 3, 2023
- FDA Inspection 1176451 - Hikma Pharmaceuticals USA Inc. - 2022-07-07 — classification: No Action Indicated (NAI), source: FDA, date: July 7, 2022
- [483 - Hikma Pharmaceuticals USA Inc. - 2019-09-10](https://www.keypedia.com/records/483/hikma-pharmaceuticals-usa-inc/0c7b12c2-a17c-44fa-946f-a65f1960d2b1) — source: FDA, date: September 10, 2019
- [FDA Inspection 1106822 - Hikma Pharmaceuticals USA Inc. - 2019-09-10](https://www.keypedia.com/records/fda_inspections/hikma-pharmaceuticals-usa-inc/607fb2a5-7932-4aff-a16c-1afe2023de82) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 10, 2019
- FDA Inspection 1067645 - Hikma Pharmaceuticals USA Inc. - 2018-09-14 — classification: No Action Indicated (NAI), source: FDA, date: September 14, 2018
- FDA Inspection 1025099 - Hikma Pharmaceuticals USA Inc. - 2017-08-18 — source: FDA, date: August 18, 2017
- FDA Inspection 1008043 - Hikma Pharmaceuticals USA Inc. - 2017-04-04 — classification: No Action Indicated (NAI), source: FDA, date: April 4, 2017
- FDA Inspection 927273 - Hikma Pharmaceuticals USA Inc. - 2015-05-21 — classification: No Action Indicated (NAI), source: FDA, date: May 21, 2015
- FDA Inspection 896197 - Hikma Pharmaceuticals USA Inc. - 2014-09-19 — classification: No Action Indicated (NAI), source: FDA, date: September 19, 2014

## Related Companies

- [Kindeva Drug Delivery Limited](https://www.keypedia.com/companies/kindeva-drug-delivery-limited/901e9a7f-5182-43e1-9980-391fca7364b7)
- [Sandoz GmbH](https://www.keypedia.com/companies/sandoz-gmbh/06a6ffcd-311c-4e6b-8087-573378a1ad87)
- [Galephar Pharmaceutical Research Inc.](https://www.keypedia.com/companies/galephar-pharmaceutical-research-inc/9718f387-543c-4e81-ae61-054ddea9a225)
- [Hospira Australia Pty Ltd.](https://www.keypedia.com/companies/hospira-australia-pty-ltd/43f04346-c63c-4c33-92ed-a42abafdd533)
- [AndersonBrecon Inc.](https://www.keypedia.com/companies/andersonbrecon-inc/799f84ea-9114-456a-83f1-7edcd7eb4d2e)
- [Carnegie Pharmaceutical Llc](https://www.keypedia.com/companies/carnegie-pharmaceutical-llc/871b6bed-cfd1-4953-90e7-bfd439dc2050)
- [Benuvia Operations, LLC](https://www.keypedia.com/companies/benuvia-operations-llc/77e6325c-aadf-4751-9ec3-b72a1a139522)
- [Kay Chemical Company](https://www.keypedia.com/companies/kay-chemical-company/a9b9e589-548c-40c1-9e78-efcf9afd5852)
- [Eminent Services Corporation](https://www.keypedia.com/companies/eminent-services-corporation/0ca8cb23-54ac-4d36-b194-8c26e09ade69)
- [Norwich Pharmaceuticals, Inc.](https://www.keypedia.com/companies/norwich-pharmaceuticals-inc/24e5093f-2fde-40ab-a0a9-518fb46c4bfd)

## Related Officers

- [Yue-Na Blaise](https://www.keypedia.com/people/yue-na-blaise/d4dc89d1-d9f1-43dc-827b-4e2a53c91cc9)
- [— Jerald Andry, MS](https://www.keypedia.com/people/jerald-andry-ms/75c94652-2f70-44db-a56f-42444bb662d9)
- [Deputy Director](https://www.keypedia.com/people/lori-m-newman/a0e448e4-11ba-4095-b879-feabb8750b3f)
- [Senior Consumer Safety Officer - Pharmaceutical Quality](https://www.keypedia.com/people/sean-r-marcsisin/45c910a9-9019-4419-9af8-b1c9f3b1e976)
